Akari Therapeutics Granted Nomacopan Orphan Drug Designation from the European Commission for Treatment in Hematopoietic Stem Cell Transplantation
NEW YORK and LONDON, July 27, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX),…
NEW YORK and LONDON, July 27, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX),…
NEW YORK and LONDON, July 27, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX),…
Preliminary data suggest a chlamydia, gonorrhea and trichomonas (CT/NG/TV) multiplex test is feasible on a…
Dr. Bronstein, the DeepMind Professor of AI at Oxford, will help VantAI unlock the potential…
Preliminary data suggest a chlamydia, gonorrhea and trichomonas (CT/NG/TV) multiplex test is feasible on a…
Dr. Bronstein, the DeepMind Professor of AI at Oxford, will help VantAI unlock the potential…
Company to receive $2 million in upfront payments, with the potential to receive up to…
Company to receive $2 million in upfront payments, with the potential to receive up to…
CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage…
CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage…
SAN DIEGO, July 27, 2023 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage…
SAN DIEGO, July 27, 2023 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage…
NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a…
NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a…
UPLIFT clinical trial did not meet its primary endpoint Company realigns focus and significantly reduces…
UPLIFT clinical trial did not meet its primary endpoint Company realigns focus and significantly reduces…
55% objective response rate; 23% complete response rate in locally advanced cSCC 50% objective response…
55% objective response rate; 23% complete response rate in locally advanced cSCC 50% objective response…
REDWOOD CITY, Calif., July 27, 2023 (GLOBE NEWSWIRE) — PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the…
REDWOOD CITY, Calif., July 27, 2023 (GLOBE NEWSWIRE) — PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the…